1. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
   Jakub Szymczyk et al, 2021, Cancers CrossRef
2. Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors (Review)
   Hong Luo et al, 2020, Oncology Letters CrossRef
3. Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway
   Hee Su Kim et al, 2023, Biomedicines CrossRef
4. Glioblastoma: Current Status, Emerging Targets, and Recent Advances
   Amandeep Thakur et al, 2022, Journal of Medicinal Chemistry CrossRef
5. Knockdown of Bcl-2-Associated Athanogene-3 Can Enhance the Efficacy of BGJ398 via Suppressing Migration and Inducing Apoptosis in Gastric Cancer
   Ke Li et al, 2021, Digestive Diseases and Sciences CrossRef
6. Magic shotgun over magic bullet for treatment of ovarian cancer via polymeric nanoparticles
   Bakr Ahmed et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
7. Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer
   Guoquan Wan et al, 2022, Journal of Medicinal Chemistry CrossRef
8. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
   Yamei Hu et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef
9. Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer
   Wei Jiang et al, 2019, Seminars in Cancer Biology CrossRef
10. FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
    Jakub Szymczyk et al, 2022, Frontiers in Oncology CrossRef